270 related articles for article (PubMed ID: 11751611)
41. Estrogen activates protein kinase C in neurons: role in neuroprotection.
Cordey M; Gundimeda U; Gopalakrishna R; Pike CJ
J Neurochem; 2003 Mar; 84(6):1340-8. PubMed ID: 12614334
[TBL] [Abstract][Full Text] [Related]
42. Progestins initiate adverse events of menopausal estrogen therapy.
Thomas T; Rhodin J; Clark L; Garces A
Climacteric; 2003 Dec; 6(4):293-301. PubMed ID: 15011717
[TBL] [Abstract][Full Text] [Related]
43. MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia.
Jover-Mengual T; Zukin RS; Etgen AM
Endocrinology; 2007 Mar; 148(3):1131-43. PubMed ID: 17138646
[TBL] [Abstract][Full Text] [Related]
44. 17beta-estradiol does not protect cerebellar granule cells from excitotoxicity or apoptosis.
Miñano A; Cerbón MA; Xifró X; Malagelada C; Aguilera J; Rodríguez-Alvarez J
J Neurochem; 2007 Jul; 102(2):354-64. PubMed ID: 17596211
[TBL] [Abstract][Full Text] [Related]
45. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
46. Rescue from Sexually Dimorphic Neuronal Cell Death by Estradiol and PI3 Kinase Activity.
Cheng HY; Hung SH; Chu PJ
Cell Mol Neurobiol; 2016 Jul; 36(5):767-75. PubMed ID: 26369912
[TBL] [Abstract][Full Text] [Related]
47. Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone.
Lundeen SG; Zhang Z; Zhu Y; Carver JM; Winneker RC
J Steroid Biochem Mol Biol; 2001 Aug; 78(2):137-43. PubMed ID: 11566438
[TBL] [Abstract][Full Text] [Related]
48. Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways.
Xia Y; Xing JZ; Krukoff TL
Neuroscience; 2009 Aug; 162(2):292-306. PubMed ID: 19410635
[TBL] [Abstract][Full Text] [Related]
49. The neuroprotective action of pyrroloquinoline quinone against glutamate-induced apoptosis in hippocampal neurons is mediated through the activation of PI3K/Akt pathway.
Zhang Q; Shen M; Ding M; Shen D; Ding F
Toxicol Appl Pharmacol; 2011 Apr; 252(1):62-72. PubMed ID: 21320517
[TBL] [Abstract][Full Text] [Related]
50. Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells.
Simoncini T; Caruso A; Giretti MS; Scorticati C; Fu XD; Garibaldi S; Baldacci C; Mannella P; Fornari L; Genazzani AR
Fertil Steril; 2006 Oct; 86(4 Suppl):1235-42. PubMed ID: 16963030
[TBL] [Abstract][Full Text] [Related]
51. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
52. The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment.
Lippert C; Seeger H; Wallwiener D; Mueck AO
Eur J Gynaecol Oncol; 2001; 22(5):331-5. PubMed ID: 11766732
[TBL] [Abstract][Full Text] [Related]
53. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells.
Simoncini T; Mannella P; Fornari L; Caruso A; Willis MY; Garibaldi S; Baldacci C; Genazzani AR
Endocrinology; 2004 Dec; 145(12):5745-56. PubMed ID: 15358673
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of MLK3-MKK4/7-JNK1/2 pathway by Akt1 in exogenous estrogen-induced neuroprotection against transient global cerebral ischemia by a non-genomic mechanism in male rats.
Wang R; Zhang QG; Han D; Xu J; Lü Q; Zhang GY
J Neurochem; 2006 Dec; 99(6):1543-54. PubMed ID: 17064355
[TBL] [Abstract][Full Text] [Related]
55. Progesterone-induced neuroprotection: factors that may predict therapeutic efficacy.
Singh M; Su C
Brain Res; 2013 Jun; 1514():98-106. PubMed ID: 23340161
[TBL] [Abstract][Full Text] [Related]
56. Transcriptional profiles of progestogen effects in the postmenopausal breast.
Wood CE; Register TC; Cline JM
Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
[TBL] [Abstract][Full Text] [Related]
57. Progesterone and medroxyprogesterone acetate differentially regulate alpha4 subunit expression of GABA(A) receptors in the CA1 hippocampus of female rats.
Pazol K; Northcutt KV; Patisaul HB; Wallen K; Wilson ME
Physiol Behav; 2009 Apr; 97(1):58-61. PubMed ID: 19394921
[TBL] [Abstract][Full Text] [Related]
58. Progestins and estrogens and Alzheimer's disease.
Honjo H; Iwasa K; Kawata M; Fushiki S; Hosoda T; Tatsumi H; Oida N; Mihara M; Hirasugi Y; Yamamoto H; Kikuchi N; Kitawaki J
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):305-8. PubMed ID: 15860274
[TBL] [Abstract][Full Text] [Related]
59. Attenuation of mitochondrial and nuclear p38α signaling: a novel mechanism of estrogen neuroprotection in cerebral ischemia.
Han D; Scott EL; Dong Y; Raz L; Wang R; Zhang Q
Mol Cell Endocrinol; 2015 Jan; 400():21-31. PubMed ID: 25462588
[TBL] [Abstract][Full Text] [Related]
60. 17β-estradiol protects dopaminergic neurons in organotypic slice of mesencephalon by MAPK-mediated activation of anti-apoptosis gene BCL2.
Wang S; Ren P; Li X; Guan Y; Zhang YA
J Mol Neurosci; 2011 Oct; 45(2):236-45. PubMed ID: 21327582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
